ℹ️
🇬🇧
Search
Search for people relevant for "EFEKTU"
EFEKTU
Person
Class
Person
Publication
Programmes
RNDr. Kamila Hladíková Ph.D.
External person at Second Faculty of Medicine
10 publications
Publications
publication
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC
2021 |
Central Library of Charles University, Second Faculty of Medicine, First Faculty of Medicine
publication
Immunological Network in Head and Neck Squamous Cell Carcinoma-A Prognostic Tool Beyond HPV Status
2020 |
Central Library of Charles University, First Faculty of Medicine
publication
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8(+) T cells
2019 |
Central Library of Charles University, Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
2019 |
Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1
2018 |
Second Faculty of Medicine, Faculty of Science, First Faculty of Medicine
publication
Squamous Cell Carcinoma of Head and Neck and Immune System
2016 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines
2016 |
Second Faculty of Medicine
publication
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
2015 |
Second Faculty of Medicine, Faculty of Science, First Faculty of Medicine
publication
Immune system in patients with head and neck carcinoma
2015 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs
2014 |
Central Library of Charles University, Second Faculty of Medicine
Loading network view...